OTC HIV tests: 42% of at-risk survey respondents "likely" to use test -- NEJM study.
This article was originally published in The Tan Sheet
Executive Summary
HOME HIV TESTS: 42% OF AT-RISK INDIVIDUALS SURVEYED WOULD "LIKELY" USE such tests if they were approved by FDA for over-the-counter use, according to a study published in the May 11 New England Journal of Medicine. Kathryn Phillips, PhD, University of California, San Francisco, et al. noted that 42% of 2,523 respondents to a national health survey who were considered at risk for HIV said they would be "very or somewhat likely to use home tests" for the virus. Sixty-three percent of this group said they had never been tested for HIV, excluding testing for blood donations.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning